Autosomal recessive spinocerebellar ataxia 9
Alternate names[edit]
Autosomal recessive ataxia due to ubiquinone deficiency; ARCA2; Autosomal recessive ataxia due to coenzyme Q10 deficiency; Autosomal recessive cerebellar ataxia type 2; Autosomal recessive spinocerebellar ataxia type 9; SCAR9
Definition[edit]
This syndrome is characterised by childhood-onset progressive ataxia and cerebellar atrophy.
Epidemiology[edit]
Prevalence is unknown.
Cause[edit]
- The syndrome is caused by ubiquinone deficiency.
- Mutations in the ADCK3/CABC1 gene have been detected in affected individuals.
- This gene is already known to play a role in ubiquinone biosynthesis in yeast.
Signs and symptoms[edit]
Exercise intolerance with elevated lactate levels and mild intellectual deficit may also be present.
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. 80%-99% of people have these symptoms
30%-79% of people have these symptoms
- Brisk reflexes
- Central hypotonia
- Developmental regression(Loss of developmental milestones)
- Exercise intolerance(Decreased ability to exercise)
- Focal T2 hypointense basal ganglia lesion
- Intellectual disability, moderate(IQ between 34 and 49)
- Proximal muscle weakness(Weakness in muscles of upper arms and upper legs)
- Talipes cavus equinovarus
5%-29% of people have these symptoms
- Abnormal pyramidal sign
- EMG abnormality
- Increased CSF lactate
- Increased serum lactate
- Lactic acidosis(Increased lactate in body)
- Myoclonus
- Neurodevelopmental delay
- Seizure
- Strabismus(Cross-eyed)
- Tremor
1%-4% of people have these symptoms
- Dystonia
- Gynecomastia(Enlarged male breast)
- Hearing impairment(Deafness)
Diagnosis[edit]
Treatment[edit]
NIH genetic and rare disease info[edit]
Autosomal recessive spinocerebellar ataxia 9 is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Autosomal recessive spinocerebellar ataxia 9
|
| This article is a stub. You can help WikiMD by registering to expand it. |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian